FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/05/087640 [Registered on: 26/05/2025] Trial Registered Prospectively
Last Modified On: 15/05/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Medical Device 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A randomized control trial comparing recovery profile of patients posted for tympanoplasty under total intravenous anaesthesia with qCON and BIS guided depth of anaesthesia monitoring systems 
Scientific Title of Study   A randomized control trial comparing recovery profile of patients posted for tympanoplasty under total intravenous anaesthesia with qCON and BIS guided depth of anaesthesia monitoring systems 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Siddhant Sugandhi 
Designation  Post Graduate Student 
Affiliation  Bharati Hospital and Research Centre 
Address  Dept. of Anaesthesiology, Bharati Hospital and Research Centre

Pune
MAHARASHTRA
411043
India 
Phone  8527755733  
Fax    
Email  sidsang1@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Abhay Sancheti 
Designation  Professor 
Affiliation  Bharati Hospital and Research Centre 
Address  Dept. of Anaesthesiology, Bharati Hospital and Research Centre

Pune
MAHARASHTRA
411043
India 
Phone  9371107686  
Fax    
Email  drabhaysancheti19@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Siddhant Sugandhi 
Designation  Post Graduate Student 
Affiliation  Bharati Hospital and Research Centre 
Address  Dept. of Anaesthesiology, Bharati Hospital and Research Centre

Pune
MAHARASHTRA
411043
India 
Phone  8527755733  
Fax    
Email  sidsang1@gmail.com  
 
Source of Monetary or Material Support  
Bharati Hospital and Research Centre, Pune-Satara Road, Pune-411043, Maharashtra, India 
 
Primary Sponsor  
Name  Bharati Hospital and Research Centre Pune 
Address  Bharati Hospital and Research Centre, Pune-Satara Road, Pune-411043, Maharashtra, India 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DR SIDDHANT SUGANDHI  BHARATI VIDYAPEETH MEDICAL COLLEGE AND HOSPITAL  Department of Anaesthesia, 3rd Floor, Beside OT Complex, Bharati Hospital and Research Centre, Pune-Satara Road, Dhankawadi, Pune -411043, Maharashtra
Pune
MAHARASHTRA 
8527755733

sidsang1@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
BHARATI VIDYAPEETH MEDICAL COLLEGE INSTITUTIONAL ETHICS COMMITTEE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: H958||Other intraoperative and postprocedural complications and disorders of the ear and mastoid process, not elsewhere classified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  BIS Monitor  Bispectral Index (BIS Index) and qCON are numerical processed, clinically confirmed EEG parameters obtained by combining several advanced technologies which are combined to optimize the correlation between EEG and clinical effects of Anaesthesia. They are monitors which will be connected to patients using electrodes placed on patients head from the beginning of anaesthesia till the patient becomes conscious and oriented. 
Comparator Agent  qCON Monitor  Bispectral Index (BIS Index) and qCON are numerical processed, clinically confirmed EEG parameters obtained by combining several advanced technologies which are combined to optimize the correlation between EEG and clinical effects of Anaesthesia. They are monitors which will be connected to patients using electrodes placed on patients head from the beginning of anaesthesia till the patient becomes conscious and oriented. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1. All elective tympanoplasty surgeries under Total Intravenous Anaesthesia lasting between 1.5 to 3 hours

2.Patient categorized under American Society of Anaethesiology Categories I, II and III. 
 
ExclusionCriteria 
Details  1. Patients categorized under American Society of Anaethesiology Categories IV and above.

2. Patients unwilling to sign the written consent.

3. Patients that require mechanical ventilation or do not have a patent airway. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Not Applicable 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
To compare time for eye opening of patients posted for tympanoplasty under total intravenous anaesthesia with qCON and BIS guided depth of anaesthesia monitoring systems.  After stopping of Infusions. Time at which primary outcome is achieved will be noted down 
 
Secondary Outcome  
Outcome  TimePoints 
i. To compare the amount of Propofol required per hour between qCON & BIS guided depth of anaesthesia monitoring systems.  After the stopping of infusions. Immediately after the surgery gets over 
ii. To evaluate the Ramsay Sedation Score- 0, 15 & 30 mins after the end of infusion & compare them for qCON & BIS guided depth of anaesthesia monitoring systems  0, 15 & 30 mins after the end of infusion 
 
Target Sample Size   Total Sample Size="54"
Sample Size from India="54" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   26/05/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - All of the individual participant data collected during the trial, after de-identification.

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response -  Statistical Analysis Plan
    Response - Informed Consent Form
    Response - Clinical Study Report
    Response -  Analytic Code

  3. Who will be able to view these files?
    Response - Anyone

  4. For what types of analyses will this data be available?
    Response - Any purpose.

  5. By what mechanism will data be made available?
    Response - Proposals should be directed to [sidsang1@gmail.com].

  6. For how long will this data be available start date provided 01-06-2026 and end date provided 01-12-2026?
    Response - Immediately following publication. No end date.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - nil
Brief Summary  

      Study will be conducted after taking approval from Central Scientific Review committee, Institutional Ethical committee and CTRI registration.

      Patients undergoing tympanoplasty will be screened for the study.

      All the eligible patients as per the inclusion and exclusion criteria, will be explained about the nature, purpose and methodology of the study with the help of a participant information sheet and informed consent will be taken.

      It will be explained to the patient that they will be blinded as to which depth of anaesthesia monitor will be applied intra-operatively in their procedure.

      The patient will then be randomly allocated by computer-based program to one of the two groups - 

a.      GROUP A –Patients in which Depth will be monitored by qCON

b.     GROUP B –Patients in which Depth will be monitored by BIS.

      Patients’ details will be filled according to proforma.

      All patients will be kept nil per oral 6 hours prior to surgery.

      Monitors will be attached, and IV line secured with 20 G cannula. Vitals and other parameters to be recorded.       

      Anaesthesia plan will be Total Intravenous Anaesthesia with supplemental oxygen using nasal prongs.

       Inj. Midazolam 0.05mg/kg for premedication, Inj. Remifentanil 0.5 mcg/kg/min infusion and Inj. Propofol 2mg/kg for induction. Maintenance will be done with Inj. Propofol 50mcg/kg/min infusion.

      The dose of Propofol infusion will be adjusted intraoperatively every 10 mins guided by BIS/qCON systems, maintaining a score of 40-60. For every increase/decrease in score by 10, propofol infusion will be changed by 10mcg/kg/min respectively. Number of patient movements and Propofol adjustments will be noted.

      Infusions will be stopped at the end of the surgery. Then, the time taken for eye-opening of the patient, from the end of infusions will be noted and the amount of Inj. Propofol used per hour during the surgery will be calculated.

      Once the patient is shifted in Post Anesthesia Care Unit, sedation will be assessed using Ramsay Sedation Scale as follows at 0, 15 and 30 mins post eye opening.

 
Close